Erfolgreiche langzeittherapie bei Stewart-Bluefarb-syndrom

Translated title of the contribution: Successful long-term therapy of Stewart-Bluefarb syndrome

Sabine Utermann*, Birgit Kahle, Detlef Petzoldt

*Corresponding author for this work
19 Citations (Scopus)


The Stewart-Bluefarb syndrome is defined as an unilateral angiodermatitis due to multiple arterio-venous fistules accompanied by acroangiodermatitis resembling Kaposi sarcoma (pseudo-kaposi sarcoma). The acroangiodermatitis is most common on the lower limb. It leads to ulcerated nodules with a high risk of bleeding and infection, as well as edema, pain and seldom limb hypertrophy. Curative therapy requires elimination of the arteriovenous shunts. Surgical destruction of the multiple small fistulae is a limitating factor. A better alternative is embolisation, but this approach carries the risk of ischemia and necrosis. A 32 year old female patient with Stewart-Bluefarb syndrome is presented; she has been successfully treated with embolisation on eight occasions.

Translated title of the contributionSuccessful long-term therapy of Stewart-Bluefarb syndrome
Original languageGerman
Issue number5
Pages (from-to)336-339
Number of pages4
Publication statusPublished - 05.2000


Dive into the research topics of 'Successful long-term therapy of Stewart-Bluefarb syndrome'. Together they form a unique fingerprint.

Cite this